Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 ,inter alia, to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2025 and to consider the declaration of dividend, if any, on the equity shares of the Company for the financial year 2024-25.